POP Biotechnologies and EuBiologics’ EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial
POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top-line interim results of a Phase 3 clinical trial of...
Deputy Editor
POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top-line interim results of a Phase 3 clinical trial of...
In a display of commitment to community welfare and affordable housing initiatives, CEO Jana Seaman and the dedicated team at...
Exclusive interview with Andy Cunningham, the CEO of Cunningham Collective, a renowned expert in brand positioning, and author of the...
If you are looking to take your business to the next level, it is important to have a solid plan...
The Washington Speakers Bureau's prestigious list of speakers has grown with the inclusion of Paula Faris, a highly respected journalist,...
With the support of customers, Jim Ellis Automotive Group closed out the sixth annual Holiday Giving Campaign with a $65,000...
Tangipahoa Parish School System and NOLA Education proudly hosted community members as well as local and state dignitaries, with special...
The jewelry industry is a luxurious one that many have attempted to modernize. However, only a few individuals have truly...
Jackson State University's Fall 2022 commencement was a celebration of the ultimate academic milestone for the more than 500 graduates...
FINDINGS, the supply chain automation company, announced today that it is officially partnered with STE (stengg.com), the leading cybersecurity services...
© 2025 The Hudson Weekly. Published by The Ritz Herald. Editions: Markets Herald • Lincoln Citizen • Madison Graph • Belmont Star • Fairmont Post
Address: 1177 6th Avenue, 5th Floor, New York, NY 10036. Removals: pr@hudsonweekly.com. Phone: (718) 313-5252. M-F: 9AM-5PM. Privacy Policy